Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Free Communications

Diabetes

HbA1c Level as a Predictive Marker of Progression to Clinical Diabetes
Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic
hrp0082fc3.2
Improved Hepatic Insulin Sensitivity in Children Randomized to CSII Treatment from Onset of Type 1 Diabetes
aPediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institute and University Hospital, Stockholm, Sweden; bDepartment of Pediatrics, Gävle Hospital, Gävle, Sweden; cDepartment of Pediatrics, Northern Älvsborgs Hospital, Trollhättan, Sweden; dDivision of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
hrp0082fc3.3
Genetics of Paediatric Type 2 Diabetes: ABCC8 Mutation in Obesity-Associated Insulin Secretion Defects
aInstitute of Experimental Paediatric Endocrinology, Charité, Berlin, Germany; bExperimental and Clinical Research Center, Charité, Berlin, Germany; cInterdisciplinary Social Paediatric Center, Charité, Berlin, Germany
hrp0082fc3.4
Pancreatic N-Methyl-D-Aspartate Receptors as Novel Drug Targets for The Treatment of Diabetes Mellitus
aDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital, Düsseldorf, Germany; bInstitute of Metabolic Physiology, Heinrich-Heine University, Düsseldorf, Germany; cInstitute for Beta Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, Düsseldorf, Germany; dGerman Center for Diabetes Research (DZD e.V.), Helmholtz Zentrum München, Neuherberg, Germany; eProfil Institute for Clinical Research, Neuss, Germany; fInstitute of Neuro- and Sensory Physiology, University Hospital Düsseldorf, Düsseldorf, Germany; gInstitute of Physiology, Medical Faculty, Centre for Open Innovations and Research, University of Maribor, Maribor, Slovenia; hMLM Medical Labs GmbH, Mönchengladbach, Germany; iDiabetes Research Institute (DRI), San Raffaele Scientific Institute, Milan, Italy; jThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden
hrp0082fc3.5